
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

Podcast: PBM Problems (Part 3): Monopoly Power in Prescription Drug Markets with Luke Slindee, PharmD
We all know the cost of prescription drugs in the U.S. is a problem. How did we get here and what can we do about it?
From the podcast MTVA Unscripted: Empowering the Move to Value Based Healthcare
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.